ADIPOQ and metabolic syndrome: The accumulation of visceral fat, a key factor in MetS, is associated with decreased levels of adiponectin and its receptors (types 1 and 2), leading to impaired insulin sensitivity and oxidative metabolism in individuals with MetS [25].